Search Results - "Jin, Dehao"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease by Yang, Guang, Li, Yuzi, Cui, Lan, Jiang, Haiying, Li, Xiang, Jin, Chunzi, Jin, Dehao, Zhao, Guangxian, Jin, Jiyong, Sun, Rui, Piao, Limei, Xu, Wenhu, Fang, Chenghu, Lei, Yanna, Yuan, Kuichang, Xuan, Chunhua, Ding, Dazi, Cheng, Xianwu

    Published in PloS one (21-09-2016)
    “…Dipeptidyl peptidase-4 (DPP4) is one of the most potent mammalian serine proteases participated in the pathogenesis of subclinical atherosclerosis. Here we…”
    Get full text
    Journal Article
  2. 2

    Increased serum cathepsin K in patients with coronary artery disease by Li, Xiang, Li, Yuzi, Jin, Jiyong, Jin, Dehao, Cui, Lan, Li, Xiangshan, Rei, Yanna, Jiang, Haiying, Zhao, Guangxian, Yang, Guang, Zhu, Enbo, Nan, Yongshan, Cheng, Xianwu

    Published in Yonsei medical journal (01-07-2014)
    “…Cathepsin K is a potent collagenase implicated in human and animal atherosclerosis-based vascular remodeling. This study examined the hypothesis that serum…”
    Get full text
    Journal Article
  3. 3

    Modified Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab for Advanced HCC: Two Case Reports by Tian, Yuan, Jin, Wenbiao, Sun, Honghua, Jin, Dehao, Kang, Dongxu, Li, Zhiyu, Piao, Longzhen

    Published in Journal of hepatocellular carcinoma (01-09-2023)
    “…Yuan Tian,1,* Wenbiao Jin,1,* Honghua Sun,1 Dehao Jin,2 Dongxu Kang,1 Zhiyu Li,1 Longzhen Piao1 1Department of Oncology, The Affiliated Hospital of Yanbian…”
    Get full text
    Journal Article
  4. 4

    Modified Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab for Advanced HCC: Two Case Reports by Tian, Yuan, Jin, Wenbiao, Sun, Honghua, Jin, Dehao, Kang, Dongxu, Li, Zhiyu, Piao, Longzhen

    Published in Journal of hepatocellular carcinoma (01-01-2023)
    “…BackgroundAdvanced-stage hepatocellular carcinoma (HCC), especially huge HCC or portal vein tumour thrombus (PVTT), is difficult to treat, and the prognosis is…”
    Get full text
    Report